Sigma-Tau S.p.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile by GlobalData

VIEWS: 0 PAGES: 54

More Info
									                    Sigma-Tau S.p.A. - Pharmaceuticals & Healthcare - Deals and Alliances
                                                  Profile
       Reference Code: GDPH32969D                                                                                                               Publication Date: MAR 2013

      Company Overview                                                                                         Key Facts
      Sigma-Tau S.p.A. (Sigma-Tau) is an Italy based pharmaceutical company. The
                                                                                                               Sigma-Tau S.p.A., Pharmaceuticals & Healthcare,
      company offers products for therapeutic areas such as urologic, bone metabolism
                                                                                                               Key Facts, 2010
      and osteoporosis, gastroenterology, cardiovascular and metabolic, rheumatologic,
      neurological, oncological areas, respiratory, and infectious disease. It also carries                     Web Address                         www.sigma-tau.it
      research in the areas of metabolism, oncology, cardiovascular disease, central and
                                                                                                                Revenue (US$ million)                                      897.59
      peripheral nervous system, and immunology. It operates research centers in Settimo
      Milanese, Pomezia, and Piana di Monte Verna in Italy; and Mendrisio in Switzerland.                       Number of Employees                                         2,441
      The company operates through its subsidiaries with operations in Europe, Africa and                       GlobalData
      North America.

      Financial Deals Landscape
        Sigma-Tau S.p.A., Pharmaceuticals & Healthcare, Deals by Type,                    Sigma-Tau S.p.A., Pharmaceuticals & Healthcare, Deals By
        2007 to YTD 2013                                                                  Year, 2007 to YTD 2013

                                                                                                          10
                                                                                                                                       8
                                                                                                          8

                                                                                           No. of Deals   6                  5                      5
                                                                                                                                            4
                                                                                                          4
                                                                                                                   2
                                                                                                          2
                                                                                                                                                             0         0
                                                                                                          0
                                                                                                                 2007       2008   2009    2010    2011     2012   YTD
                                                                                                                                                                   2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from        from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Sigma-Tau S.p.A., Pharmaceuticals & Healthcare, Deals By                         Sigma-Tau S.p.A., Pharmaceuticals & Healthcare, Deals By
         Region, 2007 to YTD 2013                                                         Therapy Area, 2007 to YTD 2013

                         20     17                                                                        12           11
          No. of Deals




                                                                                                          10
                                                                                           No. of Deals




                         15
                                                                                                          8
                         10              6                                                                                         6        6
                                                                                                          6                                             5          5
                         5                        3         3        3
                                                                                                          4
                         0
                                                                                                          2
                              North    Europe   Asia-     Middle   South
                              Americ            Pacific    East     and                                   0
                                a                          and     Central                                        Gastroi Dermat Oncolo            Cardio Infectio
                                                          Africa   Americ                                         ntestin ology    gy              vascula    us
                                                                     a                                               al                               r    D isea…



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Sigma-Tau S.p.A. - Pharmaceuticals & Healthcare - Deals and                                                                                        Reference Code: GDPH32969D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                          Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 4
       Sigma-Tau S.p.A., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ..................................................................... 5
       Sigma-Tau S.p.A., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ...................................................................... 6
       Sigma-Tau S.p.A., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ................................................................. 7
       Sigma-Tau S.p.A., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ....................................................... 8
       Sigma-Tau S.p.A., Medical Devices Deals, 2007 to YTD 2013 .......................................................................................................... 9
       Sigma-Tau S.p.A., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ................................................................. 10
       Sigma-Tau S.p.A., Pharmaceuticals & Healthcare, Deal Details ...................................................................................................... 12
          Asset Purchase............................................................................................................................................................................. 12
             Sigma-Tau Acquires Specialty Pharma Business From Enzon Pharma ................................................................................... 12
             Sigma-Tau Pharma Acquires Chenix From Solvay Pharma...................................................................................................... 15
             Sigma-Tau Pharma Acquires Chenofalk ................................................................................................................................... 16
          Partnerships.................................................................................................................................................................................. 17
             Dyax Amends Co-Development Agreement With Defiante Farmaceutica For Kalbitor ............................................................. 17
             Dyax Expands Its Agreement With Defiante Farmaceutica ....................................................................................................... 18
             Dyax Expands Its Collaboration With Defiante Farmaceutica ................................................................................................... 19
             Dyax Enters Into Co-Development Agreement With Defiante Farmaceutica ............................................................................ 20
             Endotis Pharma Enters Into Co-development Agreement With Tecnogen ................................................................................ 22
             Endotis Enters Into Manufacturing And Co-Development Agreement With Tecnogen.............................................................. 24
             Sigma-Tau Pharma Signs Partnership Agreement With Danisco Bioactive .............................................................................. 25
             Anesiva Expands Its Agreement With Sigma-Tau..................................................................................................................... 26
             Anesiva Entered Into Agreement With Sigma-Tau .................................................................................................................... 27
             Walter Reed Army Institute of Research And U.S. Army Medical Materiel Development Activity Form Partnership With Sigma-
             Tau Pharma .............................................................................................................................................................................. 28
          Licensing Agreements .................................................................................................................................................................. 29
             Soligenix Expands Licensing Agreement With Sigma-Tau Pharma For orBec ......................................................................... 29
             Gentium Enters Into Licensing Agreement With Sigma-Tau Pharma........................................................................................ 30
             DOR BioPharma Enters Into Licensing Agreement With Sigma-Tau Pharma For orBec .......................................................... 32
             Pfizer Enters Into Licensing Agreement With Sigma-Tau.......................................................................................................... 33
          Equity Offering .............................................................................................................................................................................. 34
             RegeneRx BioPharma Completes Registered Direct Offering Of $1.45 Million ........................................................................ 34
             Soligenix Completes Private Placement Of Its Common Stock For $6 Million .......................................................................... 36
             RegeneRx BioPharma Completes Private Placement Of $1 Million .......................................................................................... 38
             DOR BioPharma Completes Private Placement Of $4.39 Million.............................................................................................. 40
             Soligenix Completes Private Placement Of $4.5 Million ............................................................................................................ 42
             DOR BioPharma Completes Private Placement Of $1.5 Million ................................................................................................ 44
             RegeneRx BioPharma Completes Private Placement Of $5 Million .......................................................................................... 46
             DOR BioPharma Completes Private Placement Of $1 Million................................................................................................... 48
       Sigma-Tau S.p.A. - Key Competitors ............................................................................................................................................... 50
       Key Employees ................................................................................................................................................................................ 51
       Locations And Subsidiaries .............................................................................................................................................................. 52
          Head Office ................................................................................................................................................................................... 52
          Other Locations & Subsidiaries ..................................................................................................................................................... 52
       Appendix .......................................................................................................................................................................................... 54

Sigma-Tau S.p.A. - Pharmaceuticals & Healthcare - Deals and                                                                                                        Reference Code: GDPH32969D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any for
								
To top